 Poly(ethylene glycol) derivatives with proximal reactive groups |
| OF THE INVENTION The terms "group," "functional group," "moiety," "active moiety," "reactive site,"... |
|
| Devices for cloaking transplanted cells |
| A variety of devices can be used to contain or cloak a source of a therapeutic substance, often ... |
|
| Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| In one aspect of the invention, compounds of Formula (I) are provided: ##STR6## wherein: J is ##STR7... |
|
| Rectally absorbable form of L-dopa |
| What is claimed is: 1. A method of enhancing the rate of absorption of a rectally administered ... |
|
| Rectally absorbable form of L-dopa |
| What is claimed is: 1. A method of enhancing the rate of absorption of a rectally administered ... |
|
| Rectally absorbable form of L-dopa |
| What is claimed is: 1. A pharmaceutical composition for enhancing rectal absorption of L-dopa by ... |
|
| Method to treat Parkinsons disease |
| I claim: 1. The method of treatment of Parkinson's disease and related neurological syndromes which ... |
|
| Method of using cytoprotective alcohols to treat neural disease and neural injury |
| The present invention is grounded in the surprising discovery that hexacosanol and analogues and ... |
|
| Methods of treating Parkinson's disease using melanin |
| OF THE INVENTION One aspect of the present invention relates to the treatment of a mammal having a ... |
|
| Method of treating memory disorders using R-enantiomers of N-propargyl-aminoindan compounds |
| OF THE INVENTION The present invention thus provides as a novel compound the R(+)-enantiomer of N-... |
|
|
Nucleic acid probes immobilized on polystyrene surfaces
| Details |
Inventors: Sheridan, Patrick; Chang, Chu-An; Running, Joyce; Urdea, Michael S.;
Assignee: Chiron Corporation (Emeryville, CA)
Primary Examiner: Zitomer; Stephanie W.
Assistant Examiner:
Attorney, Agent or Firm: Dylan; Tyler, Goldman; Kenneth M., Blackburn; Robert P.
Nucleic acid probes are immobilized on polystyrene surfaces such as the wells of microtiter plates for use in solution phase nucleic acid sandwich hybridization assays, particularly those using large branched DNA amplification multimers, by: (a) cleansing the surface by washing it sequentially with a strong acid, a strong base, and water, (b) passively adsorbing a polypeptide having primary amino groups onto the cleansed surface, and (c) covalently bonding the probe to the adsorbed polypeptide via a base-stable bifunctional crosslinking agent, and (d) subjecting the surface to conditions that simulate the hybridization conditions used in the assay. |
|
DETAILED DESCRIPTION We claim: 1.
An article of manufacture for use in a solution phase nucleic acid sandwich hybridization assay comprising a polystyrene surface having a polypeptide adsorbed thereon and a nucleic acid probe covalently bonded to the polypeptide via a base-stable bifunctional crosslinking agent.
2.
The article of manufacture of claim 1 wherein the article is a well of a microtiter plate.
3.
The article of manufacture of claim 1 wherein the article is a bead.
4.
The article of manufacture of claim 2 wherein there are about 0.
1 to 10 pmoles of the probe on the surface.
5.
The article of manufacture of claim 4 wherein there are about 0.
4 to 0.
7 pmoles of the probe in the well surface.
6.
An article of manufacture for use in a solution phase nucleic acid sandwich hybridization assay comprising a polystyrene surface having a polypeptide adsorbed thereon and a nucleic acid probe covalently bonded to the polypeptide via a base-stable bifunctional crosslinking agent, wherein the polypeptide is poly(phe-lys), the crosslinking agent is disuccinimidyl suberate, and the nucleic acid probe is 5'-XCACCACTTTCTCCAAAGAAG-3' (SEQ ID NO: 1) where X represents the N.
sup.
4 -(6-aminocaproyl-2-aminoethyl) derivative of cytidine.
Description:
TECHNICAL FIELD This invention is in the field of nucleic acid hybridization assays.
More specifically, it relates to an improved method for immobilizing nucleic acid probes on polystyrene surfaces for the purpose of removing analyte nucleic acid from solution.
BACKGROUND ART Commonly owned U.
S.
Pat.
No.
4,868,105 describes a solution phase nucleic acid sandwich hybridization assay in which analyte nucleic acid is first hybridized in solution to a labeling probe set and to a capturing probe set in a first vessel.
The probe-analyte complex is then transferred to a second vessel that contains a solid-phase-immobilized probe that is complementary to a segment of the capturing probes.
The segments hybridize to the immobilized probe, thus removing the complex from solution
|
| Related patents |
|
|
Star polymers having multiple polyisobutylene arms emanating from a calixarene core, initiators therefor, and method for the synthesis thereof
What is claimed is: 1. A composition of matter comprising: a core component selected from the group consisting of a p-methoxy cumyl group and a calix?n!arene where n=4 ...
|
|
|
High molecular weight polymer-based prodrugs
The present invention addresses the shortcomings described above. In one aspect of the invention, compositions of formula (I) are provided: ##STR3## wherein: D is a ...
|
|
|
Non-antigenic branched polymer conjugates
OF THE INVENTION 1. POLYMER SUBSTITUENTS AND FORMULA (I) DEFINED The activated branched polymers of the present invention are preferably prepared from poly(alkylene ...
|
|
|
Substantially pure histidine-linked protein polymer conjugates
In one aspect, the present invention includes substantially pure protein-polymer conjugates. The conjugates include a protein, such as an alpha interferon, covalently ...
|
|
|
Crosslinked polymer compositions and methods for their use
The present invention discloses a crosslinked polymer composition comprising a first synthetic polymer containing two or more nucleophilic groups, and a second synthetic ...
|
|
|
Conjugation of polypeptides
OF THE INVENTION It is the object of the invention to provide polypeptide conjugates with reduced allergenicity. As described above it is well-known according to prior ...
|
|
|
High molecular weight polymer-based prodrugs
OF THE INVENTION A. THE PRODRUGS In most aspects of the invention, the prodrug compositions of the present invention contain hydrolyzable linkages between the polymer ...
|
|
|
Non-antigenic amine derived polymers and polymer conjugates
In one aspect of the invention, there are provided amine-based polymer intermediates having the formula: R--B (I) wherein (R) is a water-soluble, substantially non-...
|
|
|
Biodegradable high molecular weight polymeric linkers and their conjugates
The present invention includes compounds of the formula: (D).sub.n --M--(R.sub.1).sub.m (I) wherein (m) and (n) independently selected positive integers, preferably from ...
|
|
|
Modified polypeptides with high activity and reduced allergenicity
OF THE INVENTION The modified polypeptide of the present invention is represented by the formula: A-B.sub.n containing, as essential components, a enzyme, A, and a ...
|
|
|
Gene Therapy 
